Aspen Aerogels, Inc. Forecasted to Earn Q4 2024 Earnings of ($0.01) Per Share (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) – Equities research analysts at Roth Capital lowered their Q4 2024 earnings per share (EPS) estimates for shares of Aspen Aerogels in a research note issued to investors on Friday, May 3rd. Roth Capital analyst C. Moore now anticipates that the construction company will post earnings per share of ($0.01) for the quarter, down from their prior forecast of $0.03. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.03 per share.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.54%. The firm had revenue of $84.22 million for the quarter, compared to analysts’ expectations of $83.82 million. During the same quarter last year, the company earned ($0.20) earnings per share.

ASPN has been the subject of a number of other reports. HC Wainwright lifted their price target on Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Friday. Canaccord Genuity Group boosted their target price on Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday. Roth Mkm reiterated a “buy” rating and issued a $22.00 price target on shares of Aspen Aerogels in a research note on Tuesday, April 30th. TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. Finally, Piper Sandler upped their target price on shares of Aspen Aerogels from $20.00 to $29.00 and gave the company an “overweight” rating in a report on Friday. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $25.17.

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $25.11 on Monday. The stock has a market cap of $1.93 billion, a P/E ratio of -57.07 and a beta of 1.97. The company has a fifty day simple moving average of $16.72 and a 200-day simple moving average of $13.77. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12-month low of $5.32 and a 12-month high of $25.65.

Institutional Trading of Aspen Aerogels

Institutional investors and hedge funds have recently bought and sold shares of the business. GSA Capital Partners LLP purchased a new position in Aspen Aerogels during the 1st quarter worth $1,181,000. BNP Paribas Financial Markets boosted its stake in shares of Aspen Aerogels by 85.2% during the first quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after buying an additional 11,823 shares during the period. Bridgewater Advisors Inc. purchased a new position in shares of Aspen Aerogels during the first quarter worth about $750,000. Assenagon Asset Management S.A. acquired a new position in Aspen Aerogels in the 1st quarter valued at about $636,000. Finally, Harbour Capital Advisors LLC purchased a new stake in Aspen Aerogels during the 1st quarter valued at approximately $404,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.